Carole Ho

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
South San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Sean Weisberg, as Attorney-in-Fact for Carole Ho
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Carole Ho

Form 4 holding Director

Beam Therapeutics Inc.

Security class
Stock Option (Right to Buy)
Shares / value
33,662
Estimated value
$563,982
Report date
04 Jun 2025
Price
$24.40
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Medical Officer

Denali Therapeutics Inc.

Security class
Stock Option (right to buy)
Shares / value
62,500
Estimated value
Report date
05 Aug 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

NGM BIOPHARMACEUTICALS INC

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
05 Apr 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Carole Ho

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .